AVR: Anteris Forward P/S Multiple

Corporate emblem and logo of Anteris (AVR)

Anteris Technologies Global management is focused on identifying global partners for the distribution of innovations. The forward P/S ratio on this GURU.Markets platform chart demonstrates the result of this strategy, where 228.80 captures the value of this parameter. High margins are secured by patent protection for aortic valve bioprostheses, while operational efficiency is achieved by outsourcing production and testing to external contractors.

Anteris Technologies - AVR Forward Price-to-Revenue Multiple (period 12/14/2024 - 11/14/2026)

anteristech.com - analytical breakdowns and key metrics (AVR)

- stock price and consensus target price:
Stock Quotes Anteris Technologies|AVR - Analyst Forecast Prices
- market capitalization information:
Market Capitalization AVR|AVR - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Anteris Technologies Global|AVR - Company Net Assets|Market Capitalization to Book Value Ratio anteristech.com|AVR - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Anteris Technologies Global|AVR - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Anteris Technologies|AVR - Company Cumulative Debt|Debt to Book Capitalization Ratio AVR|AVR - Company Long-Term Debt|Company Short-Term Debt Anteris Technologies Global|Quick Ratio anteristech.com
- financial results and valuation multiples details:
AVR - Annual Net Income|Projected Future Earnings Anteris Technologies Global|AVR - Business Payback Period|Forward P/E Multiple Anteris Technologies|AVR - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AVR|AVR - Operating income before deduction of amortization|Net earnings per share for the last 12 months Anteris Technologies Global|AVR - Earnings per share for the trailing year|Quarterly EPS earnings growth anteristech.com|AVR - Net earnings per share change in current year|Net earnings per share growth forecast for next year Anteris Technologies Global
- sales and revenue data:
AVR - Company Revenue|Company Projected Revenue Anteris Technologies|AVR - Price to Sales|Forward P/S Multiple AVR
Initial company analysis:AVR (Anteris Technologies Ltd)
Original product of Anteris Technologies

Investors use this metric during initial asset screening to assess the premium paid for future business growth rates. The ratio of market value to expected annual revenue allows for a correlation between the capitalization of Anteris Technologies Global (AVR) and the risks associated with new heart valve approvals and the burn rate, which is clearly reflected in the company's forward P/S price action.

Who Anteris Technologies Global competes with

Regeneron - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio IRTC (iRhythm Technologies, Inc.)|Lantheus Medical Imaging - Forward P/S Multiple|Market Cap to Future Revenue Ratio Mineralys Corp|HTFL: Forward P/S Multiple|Forward Price-to-Revenue Multiple kestramedical.com|ESPR (Esperion) - Forward P/S Multiple|AMRN: Forward Price to Sales|Price-to-Projected Revenue Ratio Tenaya Therapeutics (TNYA)|CVRx Inc - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Milestone Pharmaceuticals MIST|Cardiol Therapeutics Inc (CRDL) - Market Cap to Future Revenue Ratio|BEAT - Price-to-Projected Revenue Ratio|TENX: Price-to-Projected Revenue Ratio|Adagio Medical Holdings Inc. (ADGM) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio BioCardia Inc (BCDA)|VTAK (Catheter Precision) - Forward P/S Multiple|ABIO - Projected Price to Revenue|Forward P/S Multiple ACST|Market Cap to Expected Sales Ratio Aerovate Therapeutics Inc.|Forward P/S Multiple VERV (Verve Therapeutics, Inc.)|Windtree Therapeutics Inc. (WINT) - Market Cap to Future Revenue Ratio